For more information on Osteoporosis/Abnormal Bone Mineral Density, studies please review our Clinical Research site.

The bone loss due to causes below can be evaluated and treated by our team

1. Osteoporosis/bone loss/low bone mineral density:
   1.  Age-related,
   2. Pre-menopausal and postmenopausal,
   3. Pregnancy and lactation-associated osteoporosis (PLO)
   4. Hypogonadism in men,
   5. Other endocrine-related osteoporosis due to Cushing syndrome/disease, hyperparathyroidism, hyperthyroidism, acromegaly, growth hormone deficiency,
   6. Drug-induced bone loss (including but not limited to glucocorticosteroids, check-point inhibitors, aromatase-inhibitors, androgen-deprivation therapy, suppressive thyroid hormone therapy),
   7. Radiation induced bone loss,
   8. Transplantation-related bone loss,
   9. Malnutrition, bariatric surgery related, vitamin D deficiency, etc.
2. Bone loss due to genetic disorders such as Osteogenesis imperfecta, McCune-Albright syndrome, Osteoporosis-pseudoglioma syndrome, cystic fibrosis, hypophosphatasia, Hypophosphatemic nephrolithiasis/osteoporosis-1, Paget’s disease of the bone, vitamin D receptor mutation.
3. Perioperative management of the osteoporosis before and after spinal and orthopedic surgeries.

Osteoporosis screening should be provided based on current recommendations of International Society of Clinical Densitometry (ISCD):

• Women aged 65 and older,
• For post-menopausal women younger than age 65 a bone density test is indicated if they have a risk factor for low bone mass such as: Low body weight, Prior fracture, High risk medication use, Disease or condition associated with bone loss,
• Women during the menopausal transition with clinical risk factors for fracture, such as low body weight, prior fracture, or high-risk medication use
• Men aged 70 and older,
• For men < 70 years of age a bone density test is indicated if they have a risk factor for low bone mass such as low body weight, prior fracture, or high-risk medication use,
• Adults with a fragility fracture
• Adults with a disease or condition associated with low bone mass or bone loss
• Adults taking medications associated with low bone mass or bone loss,
• Anyone being considered for pharmacologic therapy,
• Anyone being treated, to monitor treatment effect,
• Anyone not receiving therapy in whom evidence of bone loss would lead to treatment,
• Women discontinuing estrogen should be considered for bone density testing according to the indications listed above.

Osteoporosis foundations:

International Osteoporosis Foundation
Bone Health & Osteoporosis Foundation

The most widely recommended imaging diagnostic technique for bone mineral density assessment is DXA (dual-energy X-ray absorptiometry). DXA imaging is performed at the USF Diabetes and Endocrinology Center Clinics located at TGH Brandon Healthplex utilizing the Horizon A DXA scanner. This sophisticated densitometry system has features for assessing the BMD in the spine, hips, and forearm.  The presence of additional software can help in the evaluation for vertebral fracture/s, atypical femur fracture spectrum changes, and measurement of the trabecular bone score.

More information about the DXA technology is available at Horizon DXA System

Another modality to check bone density is Radiofrequency Echographic Multi-Spectrometry (REMS). REMS is performed on the Echolight ultrasound device. REMS is a new radiation-free FDA-cleared innovative technique for osteoporosis diagnosis that performs the analysis of bone micro-architecture with a non-ionizing approach and is based on the analysis of ultrasound signals. REMS can also be helpful to assess BMD in patients with severe bone deformities and the presence of instrumentation.

More information on the REMS technique can be found at Echolight Medical.

The USF Osteoporosis Program is has created an interactive Bone Health Fall Prevention House to help you to make the next step a safer one! The interactive house features different rooms and spaces, while giving tips of the most common causes of a fall.

For more information and to walk through the Bone Health Fall Prevention Interactive House click here.

Bone Health Resources

Fracture risk calculator by American Bone Heath, Healthy Bones Tampa Bay

Brochures and Infographics [PDFs]

• Fall Prevention Packet
• Osteoporosis Packet

Anti-osteoporosis medications support programs links:

Teriparatide (Forteo):  

• FORTEO Savings and Support
• SimpleFill FORTEO Patient Assistance Programs
• NeedyMeds - Forteo
• Alvogen Teriparatide Savings Program

Abaloparatide (Tymlos):

• Tymlos Savings Support
• Needy Meds - Abaloparatide

Romosozumasb (Evenity):

• Evenity Cost Support

Denosumab (Prolia):

• Prolia Cost Assistance
• Prolia Support & Access

The Rare Bone Disease Alliance, originally created in 2006 as a patient advocacy network and called the Rare Bone Disease Network, has grown into a strong coalition focused on educating medical professionals, expanding research, and assisting patients and communities affected by rare bone diseases.

The Alliance encourages professional, medical and scientific societies to expand their educational programs on rare bone disease and organizes its own meetings and workshops.

Alliance participants include rare bone disease physician and scientific thought leaders, the Rare Bone Disease Patient (RBDPN) organizations and pharmaceutical companies working in the rare bone field.

• Rare Bone Disease Alliance
• American Society for Bone and Mineral Research (ASBMR)
• National Osteoporosis Foundation (NOF)
• Capture the Fracture